150 related articles for article (PubMed ID: 24895585)
1. BAG3 and HIF-1 α coexpression detected by immunohistochemistry correlated with prognosis in hepatocellular carcinoma after liver transplantation.
Xiao H; Tong R; Cheng S; Lv Z; Ding C; Du C; Xie H; Zhou L; Wu J; Zheng S
Biomed Res Int; 2014; 2014():516518. PubMed ID: 24895585
[TBL] [Abstract][Full Text] [Related]
2. Defective Beclin-1 and elevated hypoxia-inducible factor (HIF)-1α expression are closely linked to tumorigenesis, differentiation, and progression of hepatocellular carcinoma.
Osman NA; Abd El-Rehim DM; Kamal IM
Tumour Biol; 2015 Jun; 36(6):4293-9. PubMed ID: 25596085
[TBL] [Abstract][Full Text] [Related]
3. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
Wang D; Zhang X; Lu Y; Wang X; Zhu L
Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
[TBL] [Abstract][Full Text] [Related]
5. BAG3 regulates epithelial-mesenchymal transition and angiogenesis in human hepatocellular carcinoma.
Xiao H; Cheng S; Tong R; Lv Z; Ding C; Du C; Xie H; Zhou L; Wu J; Zheng S
Lab Invest; 2014 Mar; 94(3):252-61. PubMed ID: 24365746
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery.
Dai CX; Gao Q; Qiu SJ; Ju MJ; Cai MY; Xu YF; Zhou J; Zhang BH; Fan J
BMC Cancer; 2009 Dec; 9():418. PubMed ID: 19948069
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of CXCL8 and HIF-1α is associated with metastasis and poor prognosis in hepatocellular carcinoma.
Li XP; Yang XY; Biskup E; Zhou J; Li HL; Wu YF; Chen ML; Xu F
Oncotarget; 2015 Sep; 6(26):22880-9. PubMed ID: 26078356
[TBL] [Abstract][Full Text] [Related]
8. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.
Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C
Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892
[TBL] [Abstract][Full Text] [Related]
9. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
[TBL] [Abstract][Full Text] [Related]
10. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract][Full Text] [Related]
11. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
[TBL] [Abstract][Full Text] [Related]
12. Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma.
Xu W; Kwon JH; Moon YH; Kim YB; Yu YS; Lee N; Choi KY; Kim YS; Park YK; Kim BW; Wang HJ
J Cancer Res Clin Oncol; 2014 Sep; 140(9):1507-15. PubMed ID: 24853275
[TBL] [Abstract][Full Text] [Related]
13. APC
Shi M; Dai WQ; Jia RR; Zhang QH; Wei J; Wang YG; Xiang SH; Liu B; Xu L
Cancer Lett; 2021 Jan; 496():144-155. PubMed ID: 33039559
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cell apoptosis by reducing HIF-1α/mTOR-mediated autophagy.
Hong F; Gao Y; Li Y; Zheng L; Xu F; Li X
World J Surg Oncol; 2020 May; 18(1):113. PubMed ID: 32473641
[TBL] [Abstract][Full Text] [Related]
15. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.
Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB
Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163
[TBL] [Abstract][Full Text] [Related]
16. Association of GRP78, HIF-1α and BAG3 Expression with the Severity of Chronic Lymphocytic Leukemia.
Ijabi R; Roozehdar P; Afrisham R; Moradi-Sardareh H; Kaviani S; Ijabi J; Sahebkar A
Anticancer Agents Med Chem; 2020; 20(4):429-436. PubMed ID: 31823704
[TBL] [Abstract][Full Text] [Related]
17. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma.
Hu F; Deng X; Yang X; Jin H; Gu D; Lv X; Wang C; Zhang Y; Huo X; Shen Q; Luo Q; Zhao F; Ge T; Zhao F; Chu W; Shu H; Yao M; Fan J; Qin W
Oncogene; 2015 Dec; 34(49):6007-17. PubMed ID: 25745995
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination.
El Shorbagy S; abuTaleb F; Labib HA; Ebian H; Harb OA; Mohammed MS; Rashied HA; Elbana KA; Haggag R
J Gastrointest Cancer; 2021 Mar; 52(1):269-279. PubMed ID: 32212089
[TBL] [Abstract][Full Text] [Related]
20. γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition.
Xiao H; Tong R; Ding C; Lv Z; Du C; Peng C; Cheng S; Xie H; Zhou L; Wu J; Zheng S
Oncotarget; 2015 Feb; 6(4):2180-92. PubMed ID: 25537504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]